BRK.B vs JAZZ · rev $371.44B vs P/E 1988, rev $2.28B
BRK.B (BRK.B) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BRK.B currently screens at market cap $0. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BRK.B and JAZZ stock pages for the full models.
Not investment advice.